TOBY’s urine-based MCED test received FDA Breakthrough Device Designation. This is the first urine-based MCED platform ...
Sarasota Memorial reported that 75% of lung cancers diagnosed through its early detection program were found at Stage I or II ...
Illumina and D3b, have announced a new data partnership aimed at accelerating research in pediatric cancer and rare disease, ...
Partner Therapeutics has submitted a supplemental Biologics License Application to the U.S. FDA for BIZENGRI, ...
BioNTech and DualityBio reported encouraging Phase 2 results for trastuzumab pamirtecan, an investigational HER2-targeted ...
FDA has accepted and granted Priority Review to the biologics license application for ifinatamab deruxtecan in adults with ...
Researchers at MD Anderson identified DPY30 as a key biomarker and epigenetic regulator that enables pancreatic tumors to ...
A new study led by UCL researchers suggests that making cancer cells more visible to the immune system could broaden the ...
Researchers from MD Anderson identified DHODH as a key metabolic driver of radiotherapy resistance in lung cancer. Radiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results